Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × maribavir × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Interventions

Cyclophosphamide 882 Rituximab 860 Vincristine 381 Etoposide 381 Cytarabine 340 fludarabine 338 Doxorubicin 338 fludarabine phosphate 318 Methotrexate 310 Dexamethasone 282 Prednisone 280 Lenalidomide 244 Filgrastim 228 Melphalan 200 Peripheral Blood Stem Cell Transplantation 184 Radiotherapy 173 Whole-Body Irradiation 171 Busulfan 163 Mycophenolic Acid 160 Bendamustine Hydrochloride 157 venetoclax 156 Granulocyte Colony-Stimulating Factor 150 ibrutinib 144 Tacrolimus 144 Bortezomib 138 obinutuzumab 124 Gemcitabine 112 Cyclosporine 109 Antilymphocyte Serum 103 Carmustine 100

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07014319 2025-12-04

MALMBA

Seoul National University Hospital

Phase 2 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡